Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
The dose escalation, based on the FDG-PET signal, is incorporated in the first ten fractions
of the radiotherapeutic treatment. The total amount of fractions is 32, equal to a standard
radiotherapeutic treatment for these types of cancers.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Acute toxicity during radiotherapy until 3 months after the end of the radiotherapy
until 3 months after the end of the radiotherapy
No
Wilfried De Neve, MD, PhD
Principal Investigator
University Hospital, Ghent
Belgium: Institutional Review Board
2003/202
NCT00135161
September 2003
August 2013
Name | Location |
---|